GeneDx Holdings Corp. (WGS) — Strategic Asset Allocation Index
GeneDx Holdings Corp. (WGS) has a Strategic Asset Allocation Index of 26.0% as of June 2023. Strategic assets (PP&E of $77.02 Million plus long-term investments of $-) total $77.02 Million, measured against net assets of $296.11 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are GeneDx Holdings Corp.'s assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
GeneDx Holdings Corp. Strategic Asset Allocation Index (2020–2022)
This chart shows how GeneDx Holdings Corp.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 26.0%, representing strategic assets of $77.02 Million against net assets of $296.11 Million USD. See financial flexibility index of GeneDx Holdings Corp. to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for GeneDx Holdings Corp. (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GeneDx Holdings Corp. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see WGS company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.2% | $84.28 Million | $84.28 Million | $- | $253.71 Million | ▲ +17.1 pp |
| 2021 | 16.2% | $62.72 Million | $62.72 Million | $- | $388.10 Million | ▼ -1422.1 pp |
| 2020 | 1438.2% | $63.11 Million | $63.11 Million | $- | $4.39 Million | — |